Search results for

Alvin Ailey's seminal Revelations is considered the most widely viewed modern dance work in the world. Lost songs from the 1960 premiere are featured in a new work and an album this season.

Vice President JD Vance laid out a vision for AI at the third AI Action Summit in Paris that is very different from the tack the Biden administration took, focusing less and less on safety.

Mpox continues to impact parts of Africa. And experts say the outbreak stands at a critical moment as the U.S. halts foreign assistance and rebel violence scramble efforts to control the virus.

Top Trump administration officials are in Europe this week, with Defense Secretary Pete Hegseth attending his first NATO meeting and Secretary of State Marco Rubio in Paris to discuss Ukraine.

What do National Institutes of Health funding cuts mean for universities? We ask Holden Thorp, editor-in-chief of the journal Science and former University of North Carolina at Chapel Hill chancellor.

Forecasters say a major rainstorm is expected to hit Los Angeles this week. What consequences could that have in the wake of the LA fires? And what are local officials doing to prepare?

Ahmir "Questlove" Thompson says that telling Sly Stone's story with empathy was a way to open a conversation about Black artists and mental health.

Christopher Wray's decision is not a huge surprise. It comes less than two weeks after President-elect Donald Trump said he wants a veteran of his first term in office, Kash Patel, to replace Wray.

NPR's Steve Inskeep talks to Gov. Jared Polis about his thoughts on the incoming Trump administration, and the power of pardons.

FIFA's selection of Saudi Arabia to host the World Cup was celebrated in the kingdom but criticized by human rights groups, who fear residents, visitors and migrant workers will be at risk of abuse.

Hurricane Katrina resulted in nearly 1,400 deaths, according to revised statistics from the National Hurricane Center, and remains the costliest storm in U.S. history at around $200 billion in today's dollars.

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from making cheaper copies. They argue they can keep up with demand on their own.